NCT06795204View on ClinicalTrials.gov

Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 9, 2024

Primary Completion Date

May 19, 2024

Study Completion Date

May 19, 2024

Conditions
Anesthesia; Adverse EffectCardiac Arrhythmia
Interventions
DRUG

HSK3486

Study Drug

DRUG

Moxifloxacin Hydrochloride

Positive Control

DRUG

Placebo

Negative Control

Trial Locations (1)

Unknown

Beijing Gobroad Boren Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Haisco-USA Pharmaceuticals, Inc.

INDUSTRY